News

News

Icon LISA News = LISA News
18.12.2018
Curetis’ Subsidiary Ares Genetics Teams Up with Leading
18.12.2018
Valneva Initiates Phase 2 Clinical Development For Its Lyme Disease Vaccine Candidate
18.12.2018
HOOKIPA Doses First Patient in a Phase 2 Clinical Trial of Prophylactic Vaccine Candidate HB-101 against Cytomegalovirus
18.12.2018
AOP Orphan announces positive CHMP opinion for Ropeginterferon alfa-2b/BESREMi®
18.12.2018
AddLife acquires Austrian Biomedica – international expansion on 13 new markets
11.12.2018
Small but versatile – Key players in the marine nitrogen cycle can utilize cyanate and urea
10.12.2018
Valneva and HOOKIPA Sign a Collaboration and Manufacturing Agreement
04.12.2018
AOP Orphan announces three-year results on Ropeginterferon alfa-2b in Polycythemia Vera at ASH
04.12.2018
AWARD FOR PHAGE THERAPY: PHAGOMED WINS AUSTRIAN ENTREPRENEURSHIP AWARD PHÖNIX
29.11.2018
EANS-Adhoc: Marinomed Biotech AG suspends offer period of the current IPO